SARM1 inhibitor - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Bristol Myers Squibb (NYSE: BMY) strengthens Camzyos growth case with positive adolescent SCOUT-HCM data

Iran strikes Kuwait and Dubai as President Pezeshkian warns Gulf neighbours over US military bases

Mumbai Indians end 13-year IPL opening match drought with six-wicket win over KKR

Representative image of satellite-based carbon monitoring over an urban-industrial region, illustrating how the Axelspace-led JAXA Space Strategy Fund project could advance source-specific CO2 emissions tracking and next-generation Earth observation in Japan.

Axelspace-led consortium wins JAXA backing for source-specific CO2 monitoring satellite project

Read More

Pharma Industry News

Nura Bio kicks off Phase 1 clinical trials for SARM1 inhibitor NB-4746

Nura Bio, a leading biopharmaceutical company specializing in neuroprotective, small molecule therapies, announced today the initiation of Phase…

byPallavi Madhiraju

August 25, 2023

web analytics